Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancerSjoerd H. den Uil, Remond J.A. Fijneman, Robbert J.C. Slebos et al.|European Journal of Cancer|2020Cited by 36